Teisuke Takahashi

(1<i>S</i>)-1,5-Anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-<scp>d</scp>-glucitol (TS-071) is a Potent, Selective Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for Type 2 Diabetes Treatment

Hiroyuki Kakinuma, Takahiro Oi, Yuko Hashimoto-Tsuchiya et al. · Journal of Medicinal Chemistry · 2010 · 154 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Diabetes Management +13

Effects of a New SGLT2 Inhibitor, Luseogliflozin, on Diabetic Nephropathy in T2DN Rats

Naoki Kojima, Jan M. Williams, Teisuke Takahashi et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 140 citations · Full text

Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia–reperfusion injuries

Kenzo Takahashi, Teisuke Takahashi, Taizo Suzuki et al. · European Journal of Pharmacology · 2002 · 109 citations

Myocardial Ischemia–reperfusion Injuries, Cardiovascular Disease, Medicine +10

Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury

Keiichi Hishikari, Jun‐ichi Suzuki, Masahito Ogawa et al. · Cardiovascular Research · 2008 · 73 citations · Full text

Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S rats

Naoki Kojima, Jan M. Williams, Tiffani Slaughter et al. · Physiological Reports · 2015 · 62 citations · Full text

Hypertension, Renal Inflammation, Rat Model +23